ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
阿里阿德
23.99
0.0000
成交量:
- -
成交額:
- -
市值:
46.59億
市盈率:
-133.28
高:
23.99
開:
23.99
低:
23.99
收:
23.99
52周最高:
23.99
52周最低:
23.99
股本:
1.94億
流通股本:
1.70億
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.1800
淨資產收益率:
--
總資產收益率:
--
市淨率:
-100.52
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
兩大巨頭接連‘踩坑’,為什麼‘藥王’也治不了阿爾茨海默症?
制药在线
·
2025/12/02
ARIA 市值現報 8037 萬美元,24 小時漲幅 26.7%
foresightnews
·
2025/11/27
瘋狂的司美格魯肽遇挫
国际金融报
·
2025/11/27
幣安上線 AriaAI 交易競賽,分享 100 萬美元等值獎勵
链捕手
·
2025/11/06
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易,超低佣金,新手也能轻松开启投资。在老虎证券, 1 美元起投资美股,24/5 无时差交易美股,澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ARIA"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ARIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","market":"US","secType":"STK","nameCN":"阿里阿德","latestPrice":23.99,"timestamp":1770411600000,"preClose":23.99,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":169700000,"shares":194200862,"eps":-0.18,"marketStatus":"休市中","change":0,"latestTime":"02-06 16:00:00 EST","open":23.99,"high":23.99,"low":23.99,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.18,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":23.99,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","floatShares":169700000,"roa":"--","roe":"--","lyrEps":0,"shares":194200862,"dividePrice":0,"high":23.99,"amplitude":0,"preClose":23.99,"low":23.99,"week52Low":23.99,"pbRate":"-100.52","week52High":23.99,"institutionHeld":0.5771,"latestPrice":23.99,"eps":-0.18,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.18,"open":23.99,"prevYearClose":23.99,"prevWeekClose":23.99,"prevMonthClose":23.99,"prevQuarterClose":23.99,"fiveDayClose":23.99,"twentyDayClose":23.99,"sixtyDayClose":23.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARIA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-07","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.19,"name":null,"time":"盤前","type":"earning","dateTimestamp":1478494800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-07-28","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1469678400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-10","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盤前","type":"earning","dateTimestamp":1462852800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-02-23","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盤前","type":"earning","dateTimestamp":1456203600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2015-11-03","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.2,"name":null,"time":"盤前","type":"earning","dateTimestamp":1446526800000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARIA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARIA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588704081","title":"兩大巨頭接連‘踩坑’,為什麼‘藥王’也治不了阿爾茨海默症?","url":"https://stock-news.laohu8.com/highlight/detail?id=2588704081","media":"制药在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588704081?lang=zh_tw&edition=fundamental","pubTime":"2025-12-02 13:55","pubTimestamp":1764654914,"startTime":"0","endTime":"0","summary":"2025年11月下旬,全球制药行业的目光被连续两起失败所吸引。11月24日,丹麦巨头诺和诺德宣布,其口服司美格鲁肽治疗早期阿尔茨海默症的两项关键III期临床试验未能达到延缓疾病进展的主要终点。短短几天后,强生公司紧随其后,宣布终止其抗tau蛋白抗体药物Posdinemab的II期临床试验,原因同样是未能显著改善患者临床症状。四天内,两家跨国药企在阿尔茨海默症这一“研发黑洞”中接连折戟。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202135532978b23bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202135532978b23bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0070217475.USD","LU2430703178.SGD","LU1894683348.USD","LU1430594728.SGD","LU0432979614.USD","LU1059921491.USD","IE00B19Z3581.USD","LU1221951046.USD","JNJ","IE00BFTCPJ56.SGD","LU0345770993.USD","LU2750360641.GBP","LU2129689514.USD","IE0002141913.USD","BK4533","LU1261432733.SGD","LU2471134523.USD","LU1057294990.SGD","IE00BSNM7G36.USD","LU1221951129.SGD","IE00BVYPNW00.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4534","LU0466842654.USD","LU1066051225.USD","LU1032955483.USD","LU0795875169.SGD","LU1066051498.USD","IE00B3T34201.USD","LU0882574055.USD","LU0345770308.USD","IE00B1BXHZ80.USD","LU2602419157.SGD","NVO","LU1894683264.USD","LU1778281490.HKD","BK4132","LU1023059063.AUD","LU1066051811.HKD","LU1506573853.SGD","LU2505996681.GBP","LU0912757837.SGD","AD","LU2592432038.USD","LU1732799900.SGD","LU1032466523.USD","LU1914381329.SGD","LU2430703251.USD","ARIA","LU2471134879.HKD"],"gpt_icon":0},{"id":"2586216451","title":"ARIA 市值現報 8037 萬美元,24 小時漲幅 26.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586216451","media":"foresightnews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586216451?lang=zh_tw&edition=fundamental","pubTime":"2025-11-27 13:09","pubTimestamp":1764220140,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://foresightnews.pro/foresightnews/news/detail/91306","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"foresightnews_live","symbols":["ARIA"],"gpt_icon":0},{"id":"2586329056","title":"瘋狂的司美格魯肽遇挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2586329056","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586329056?lang=zh_tw&edition=fundamental","pubTime":"2025-11-27 10:22","pubTimestamp":1764210153,"startTime":"0","endTime":"0","summary":"11月25日,丹麦胰岛素巨头诺和诺德公布了口服司美格鲁肽针对早期症状性阿尔茨海默病的III期evoke和evoke+临床试验的两年期主要分析结果。由于未能达到目标,该股下挫逾10%。这是疯狂了三年的“减肥神药”司美格鲁肽首次遇挫。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511273576389868.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511273576389868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["AD","BK4132","ARIA","MCI"],"gpt_icon":0},{"id":"2581951092","title":"幣安上線 AriaAI 交易競賽,分享 100 萬美元等值獎勵","url":"https://stock-news.laohu8.com/highlight/detail?id=2581951092","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581951092?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 22:02","pubTimestamp":1762437723,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,币安将在 2025 年 11 月 7 日 00:00 至 2025 年 11 月 21 日 00:00 举办 AriaAI (ARIA) 交易竞赛。活动期间,通过币安钱包(无私钥)或币安 Alpha 交易 AriaAI (ARIA) 的用户将有机会分享 5,658,000 个 ARIA 代币奖励,排名前 12,300 的用户每人可获得 460 个 ARIA。请确保您的币安 App 已更新至最新版本并创建币安钱包以参与活动。 ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2218007","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARIA"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ARIA\",params:#limit:6,delay:false,,,undefined,":[]}}